FOCUS ON
Life Sciences
The Life Sciences sector, which includes pharmaceutical, biotechnology, medical device and equipment as well as diagnostic industries, is characterized by :
-
its innovative character,
-
its international dimension,
-
its demanding regulatory framework,
-
the number, diversity and dynamics of its stakeholders (see M&A).
Identifying a leader in these industries requires a thorough knowledge of the sector as well as a trustful relationship with those who make it work. PITKER meets this dual requirement by investing every day in understanding a sector in constant change, where, beyond the science, it is the women and men who make the difference.
OUR
approach
01
Sector expertise
The Life Sciences industries represent 59% of PITKER's clients.
The firm carries out more than 3/4 of its assignments in this sector.
60% of our clients in the Life Sciences sector are pharmaceutical companies. Our other LS clients are mostly in the biotechnology, consumer health and medical device areas.
02
Level & Nature of assignments
Almost one out of five assignments in the Life Sciences sector is a search for a Group CEO (m.f.) or Country Managing Director (m.f.).
Our other assignments concern (in descending order) heads of P&L (BUD), Pharmaceutical Affairs, Human Resources, Medical Affairs, Market Access & Public Affairs, Marketing, Finance, etc. These are roles at country and Executive Committee levels.
In France or abroad (we are able to conduct searches abroad, if necessary relying on valued partners in the country concerned).
Please note that PITKER also conducts searches for non-executive board directors.
03
DNA apart
PITKER has developed challenging yet trustworthy relations with LS industry leaders.
This long-term approach enables PITKER to address high-stake searches, often conducted under strict confidentiality.
For listed, family or private equity owned companies, PITKER manages every search assignment as a priority.